Please login to the form below

Not currently logged in
Email:
Password:

Vesomni

This page shows the latest Vesomni news and features for those working in and with pharma, biotech and healthcare.

Astellas gets first OK for prostate drug Vesomni

Astellas gets first OK for prostate drug Vesomni

Astellas' new combination product for enlarged prostate problems in men has been approved in the Netherlands, its first market, under the Vesomni brand name. ... Vesomni (formerly known as EC905) is a once-daily, fixed-dose combination of the

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
SEVEN STONES

Seven Stones is a creative, independent healthcare communications agency of movers and thinkers. We've been doing health differently since 1991....

Latest intelligence

eyeforpharma Marketing and Customer Innovation Europe
By Richard Springham...
US Drug pricing
The Golden Goose
Why it’s so hard for the US to curb runaway drug prices...
What is changing in cardiovascular disease care?
Paul Midgley, of Wilmington Healthcare, explores the NHS Long-term Plan’s strategy for tackling cardiovascular disease and what it means for pharma...

Infographics